Educational information, not medical advice — ask your doctor or midwife.
Yokukansan is a classical Japanese Kampo herbal formula composed of seven botanicals that work together to calm the nervous system. It has been prescribed in Japan for over 400 years, originally for childhood irritability and nervous conditions, and is now widely studied and used for behavioral symptoms in dementia. It is one of the most clinically researched Kampo formulas in modern Japanese medicine.
Yokukansan is thought to gently modulate the brain's glutamate and serotonin systems, both of which play key roles in mood, agitation, and sleep. The Uncaria hook component contains alkaloids believed to reduce overactive nerve signaling, while the whole formula together appears to calm stress responses without heavy sedation. It may also support healthy cortisol regulation, helping the body respond to stress more smoothly.
In Japan, Yokukansan is most commonly dispensed as standardized granule powder (TJ-54 by Tsumura), which dissolves in warm water and is taken two to three times daily. Tablet forms are available for convenience. Traditional decoctions involve boiling the raw herbs. Outside Japan, liquid extracts and capsules are increasingly available through integrative health providers.
Yokukansan originates from a 16th-century Chinese medical text and was adopted into Japanese Kampo practice during the Edo period. It was classically prescribed for children's nervous irritability, night crying, and convulsions. In the 21st century, Japanese geriatric and psychiatric researchers began studying it for dementia-related behavioral symptoms, generating a substantial body of clinical trial data that has brought it international attention.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.